• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺低分化导管原位癌中显著凋亡的证据。

Evidence of significant apoptosis in poorly differentiated ductal carcinoma in situ of the breast.

作者信息

Gandhi A, Holland P A, Knox W F, Potten C S, Bundred N J

机构信息

University Department of Surgery, University Hospital of South Manchester, UK.

出版信息

Br J Cancer. 1998 Sep;78(6):788-94. doi: 10.1038/bjc.1998.580.

DOI:10.1038/bjc.1998.580
PMID:9743302
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2062978/
Abstract

Following breast-conserving surgery for ductal carcinoma in situ (DCIS), the presence of comedo necrosis reportedly predicts for higher rates of post-operative recurrence. To examine the role of programmed cell death (apoptosis) in the aetiology of the cell death described as comedo necrosis, we studied 58 DCIS samples, using light microscopy, for morphological evidence of apoptotic cell death. The percentage of apoptotic cells (apoptotic index, AI) was compared between DCIS with and without evidence of 'comedo necrosis' and related to the immunohistochemical expression of the anti-apoptosis gene bcl-2, mitotic index (MI), the cellular proliferation antigen Ki67, nuclear grade and oestrogen receptor (ER) status. AI was significantly higher in DCIS samples displaying high-grade comedo necrosis than in low-grade non-comedo samples: median AI = 1.60% (range 0.84-2.89%) and 0.45% (0.1-1.31%) respectively (P < 0.001). Increasing nuclear grade correlated positively with AI (P < 0.001) and negatively with bcl-2 expression (P = 0.003). Bcl-2 correlated negatively with AI (P = 0.019) and strongly with ER immunoreactivity (P < 0.001). Cellular proliferation markers (MI and Ki67 immunostaining) correlated strongly with AI and were higher in comedo lesions and tumours of high nuclear grade (P < 0.001 in all cases). Thus, apoptosis contributes significantly to the cell death described in ER-negative, high-grade DCIS in which a high proliferative rate is associated with a high apoptotic rate. It is likely that dysregulation of proliferation/apoptosis control mechanisms accounts for the more malignant features typical of ER negative comedo DCIS.

摘要

据报道,原位导管癌(DCIS)保乳手术后,粉刺状坏死的存在预示着术后复发率较高。为了研究程序性细胞死亡(凋亡)在被描述为粉刺状坏死的细胞死亡病因中的作用,我们使用光学显微镜研究了58例DCIS样本,以寻找凋亡细胞死亡的形态学证据。比较了有和没有“粉刺状坏死”证据的DCIS之间的凋亡细胞百分比(凋亡指数,AI),并将其与抗凋亡基因bcl-2的免疫组化表达、有丝分裂指数(MI)、细胞增殖抗原Ki67、核分级和雌激素受体(ER)状态相关联。显示高级别粉刺状坏死的DCIS样本中的AI显著高于低级别非粉刺状样本:中位AI分别为1.60%(范围0.84 - 2.89%)和0.45%(0.1 - 1.31%)(P < 0.001)。核分级增加与AI呈正相关(P < 0.001),与bcl-2表达呈负相关(P = 0.003)。Bcl-2与AI呈负相关(P = 0.019),与ER免疫反应性呈强相关(P < 0.001)。细胞增殖标志物(MI和Ki67免疫染色)与AI强烈相关,在粉刺状病变和高核分级肿瘤中更高(所有病例P < 0.001)。因此,凋亡对ER阴性、高级别DCIS中所描述的细胞死亡有显著贡献,其中高增殖率与高凋亡率相关。增殖/凋亡控制机制的失调可能是ER阴性粉刺状DCIS典型的更恶性特征的原因。

相似文献

1
Evidence of significant apoptosis in poorly differentiated ductal carcinoma in situ of the breast.乳腺低分化导管原位癌中显著凋亡的证据。
Br J Cancer. 1998 Sep;78(6):788-94. doi: 10.1038/bjc.1998.580.
2
Biological profile of in situ breast cancer investigated by immunohistochemical technique.免疫组织化学技术研究原位乳腺癌的生物学特征。
Cancer Detect Prev. 1998;22(4):313-8. doi: 10.1046/j.1525-1500.1998.cdoa41.x.
3
Thirty percent of ductal carcinoma in situ of the breast in Japan is extremely low-grade ER(+)/HER2(-) type without comedo necrosis.
J Med Invest. 2016;63(3-4):192-8. doi: 10.2152/jmi.63.192.
4
Assessment of hormone dependence of comedo ductal carcinoma in situ of the breast.乳腺粉刺型导管原位癌激素依赖性评估。
J Natl Cancer Inst. 1997 Jul 16;89(14):1059-65. doi: 10.1093/jnci/89.14.1059.
5
Apoptosis in breast cancer: relationship with other pathological parameters.乳腺癌中的细胞凋亡:与其他病理参数的关系
Endocr Relat Cancer. 1999 Mar;6(1):13-6. doi: 10.1677/erc.0.0060013.
6
Immunohistochemical detection of oestrogen receptors in ductal carcinoma in situ of the breast.乳腺导管原位癌中雌激素受体的免疫组织化学检测
Eur J Surg Oncol. 1996 Dec;22(6):578-82. doi: 10.1016/s0748-7983(96)92242-8.
7
Similarity in expression of cell cycle proteins between in situ and invasive ductal breast lesions of same differentiation grade.相同分化程度的乳腺原位导管病变与浸润性导管病变之间细胞周期蛋白表达的相似性。
J Pathol. 2001 Jul;194(3):327-33. doi: 10.1002/path.910.
8
Ideas in pathology. Ductal carcinoma in situ of the breast: a proposal for a new simplified histological classification association between cellular proliferation and c-erbB-2 protein expression.病理学观点。乳腺导管原位癌:关于一种新的简化组织学分类以及细胞增殖与c-erbB-2蛋白表达之间关联的提议。
Mod Pathol. 1994 Feb;7(2):257-62.
9
Microinvasive ductal carcinoma (T1mic) of the breast. The clinicopathological profile and immunohistochemical features of 28 cases.乳腺微浸润性导管癌(T1mic)。28例病例的临床病理特征及免疫组化特点
Pathol Int. 2003 Jul;53(7):422-8. doi: 10.1046/j.1440-1827.2003.01498.x.
10
Effects of a pure antiestrogen on apoptosis and proliferation within human breast ductal carcinoma in situ.一种纯抗雌激素对人乳腺导管原位癌细胞凋亡和增殖的影响。
Cancer Res. 2000 Aug 1;60(15):4284-8.

引用本文的文献

1
Dedifferentiation-mediated stem cell niche maintenance in early-stage ductal carcinoma in situ progression: insights from a multiscale modeling study.早期导管原位癌进展中去分化介导的干细胞龛维持:来自多尺度建模研究的见解。
Cell Death Dis. 2022 May 21;13(5):485. doi: 10.1038/s41419-022-04939-x.
2
The enigmatic roles of caspases in tumor development.细胞凋亡蛋白酶在肿瘤发生发展中的作用。
Cancers (Basel). 2010 Nov 24;2(4):1952-79. doi: 10.3390/cancers2041952.
3
Comedo-ductal carcinoma in situ: A paradoxical role for programmed cell death.粉刺样导管原位癌:程序性细胞死亡的矛盾作用。
Cancer Biol Ther. 2008 Nov;7(11):1774-82. doi: 10.4161/cbt.7.11.6781. Epub 2008 Nov 12.
4
Apoptosis and production of TNF-alpha by tumor-associated inflammatory cells in histological grade III breast cancer.III级组织学分级乳腺癌中肿瘤相关炎性细胞的凋亡及肿瘤坏死因子-α的产生
Cancer Immunol Immunother. 2005 Jul;54(7):671-6. doi: 10.1007/s00262-004-0639-0. Epub 2004 Dec 30.
5
The transcription factor DEC1 (stra13, SHARP2) is associated with the hypoxic response and high tumour grade in human breast cancers.转录因子DEC1(stra13,SHARP2)与人类乳腺癌中的低氧反应和高肿瘤分级相关。
Br J Cancer. 2004 Aug 31;91(5):954-8. doi: 10.1038/sj.bjc.6602059.
6
COX-2 expression is associated with an aggressive phenotype in ductal carcinoma in situ.环氧化酶-2(COX-2)的表达与导管原位癌的侵袭性表型相关。
Br J Cancer. 2004 Jan 26;90(2):423-9. doi: 10.1038/sj.bjc.6601534.
7
Autocrine laminin-5 ligates alpha6beta4 integrin and activates RAC and NFkappaB to mediate anchorage-independent survival of mammary tumors.自分泌层粘连蛋白-5连接α6β4整合素并激活RAC和核因子κB,以介导乳腺肿瘤的非锚定依赖性存活。
J Cell Biol. 2003 Dec 22;163(6):1397-407. doi: 10.1083/jcb.200302023.
8
Increased malignancy of Neu-induced mammary tumors overexpressing active transforming growth factor beta1.过表达活性转化生长因子β1的Neu诱导乳腺肿瘤的恶性程度增加。
Mol Cell Biol. 2003 Dec;23(23):8691-703. doi: 10.1128/MCB.23.23.8691-8703.2003.
9
In vivo cell kinetics in breast carcinogenesis.乳腺癌发生过程中的体内细胞动力学。
Breast Cancer Res. 2001;3(4):276-83. Epub 2001 Jun 5.
10
Tumour-stromal interactions. Integrins and cell adhesions as modulators of mammary cell survival and transformation.肿瘤-基质相互作用。整合素与细胞黏附作为乳腺细胞存活和转化的调节因子。
Breast Cancer Res. 2001;3(4):224-9. doi: 10.1186/bcr300. Epub 2001 Jun 14.

本文引用的文献

1
Pattern of gene alterations in intraductal breast neoplasms associated with histological type and grade.与组织学类型和分级相关的乳腺导管内肿瘤的基因改变模式。
Clin Cancer Res. 1995 Mar;1(3):261-7.
2
Assessment of hormone dependence of comedo ductal carcinoma in situ of the breast.乳腺粉刺型导管原位癌激素依赖性评估。
J Natl Cancer Inst. 1997 Jul 16;89(14):1059-65. doi: 10.1093/jnci/89.14.1059.
3
E-cadherin (E-cad) expression in duct carcinoma in situ (DCIS) of the breast.
Virchows Arch. 1997 Jan;430(1):23-8. doi: 10.1007/BF01008012.
4
What is an apoptotic index measuring? A commentary.凋亡指数衡量的是什么?一篇评论。
Br J Cancer. 1996 Dec;74(11):1743-8. doi: 10.1038/bjc.1996.624.
5
A critical appraisal of six modern classifications of ductal carcinoma in situ of the breast (DCIS): correlation with grade of associated invasive carcinoma.对六种现代乳腺导管原位癌(DCIS)分类的批判性评价:与相关浸润性癌分级的相关性
Histopathology. 1996 Nov;29(5):397-409. doi: 10.1046/j.1365-2559.1996.d01-513.x.
6
Intracellular antibody against erbB-2 mediates targeted tumor cell eradication by apoptosis.针对erbB-2的细胞内抗体通过凋亡介导靶向肿瘤细胞清除。
Cancer Gene Ther. 1996 Mar-Apr;3(2):89-98.
7
Extensive apoptosis in ductal carcinoma in situ of the breast.乳腺导管原位癌中广泛的细胞凋亡。
Cancer. 1996 May 1;77(9):1831-5. doi: 10.1002/(SICI)1097-0142(19960501)77:9<1831::AID-CNCR11>3.0.CO;2-0.
8
bcl-2 expression in the spectrum of preinvasive breast lesions.bcl-2在乳腺浸润前病变谱中的表达。
Cancer. 1996 Feb 1;77(3):499-506. doi: 10.1002/(SICI)1097-0142(19960201)77:3<499::AID-CNCR11>3.0.CO;2-#.
9
Incidence of and treatment for ductal carcinoma in situ of the breast.乳腺导管原位癌的发病率及治疗方法
JAMA. 1996 Mar 27;275(12):913-8.
10
Ductal carcinoma in situ (intraductal carcinoma) of the breast treated with breast-conserving surgery and definitive irradiation. Correlation of pathologic parameters with outcome of treatment.采用保乳手术和根治性放疗治疗的乳腺导管原位癌(导管内癌)。病理参数与治疗结果的相关性。
Cancer. 1993 Apr 15;71(8):2532-42. doi: 10.1002/1097-0142(19930415)71:8<2532::aid-cncr2820710817>3.0.co;2-0.